Real life studies and good clinical practice - Authors' reply
Lancet Haematol
.
2016 Apr;3(4):e160-1.
doi: 10.1016/S2352-3026(16)00027-2.
Authors
Walter Ageno
1
,
Lorenzo G Mantovani
2
,
Sylvia Haas
3
,
Reinhold Kreutz
4
,
Danja Monje
5
,
Jonas Schneider
6
,
Martin van Eickels
6
,
Martin Gebel
7
,
Elizabeth Zell
8
,
Alexander G G Turpie
9
Affiliations
1
Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy. Electronic address: walter.ageno@uninsubria.it.
2
CESP-Center for Public Health Research, University of Milan Bicocca, Milan, Italy.
3
Vascular Centre, Munich, Germany.
4
Institute of Clinical Pharmacology and Toxicology, Charité-Universitätsmedizin, Berlin, Germany.
5
Bayer Vital GmbH, Leverkusen, Germany.
6
Bayer Pharma AG, Berlin, Germany.
7
Bayer Pharma AG, Wuppertal, Germany.
8
Stat-Epi Associates Inc, Ponte Vedra Beach, FL, USA.
9
Department of Medicine, Hamilton Health Sciences, General Division, Hamilton, ON, Canada.
PMID:
27063973
DOI:
10.1016/S2352-3026(16)00027-2
No abstract available
Publication types
Letter
Comment
MeSH terms
Humans
Life*